The Master Class on Successful and Practical Strategies for Patenting Antibody-Related Inventions
When
November 30, 2012
Contact Information
CustomerService@AmericanConference.com
Deirdre Sanders, Principal at Hamilton Brook Smith Reynolds, co-presented "The Master Class on Successful and Practical Strategies for Patenting Antibody-Related Inventions" at the American Conference Institute's 14th Advanced Forum on Biotech Patents. The conference runs from November 28-30 at the Hyatt Regency in Boston.
Presentation Highlights
Immunological innovations are central to the biotechnology industry and in light of uncertainty surrounding the patenting of genes, protecting this intellectual property is more important than ever. Nevertheless, the difficulties of antibody and other immune-related patenting have been drastically amplified in recent years. Due to the uncertainty created by trends highlighted in Prometheus and Myriad, the “obvious to try” strictures of In re Kubin, the narrowing of allowable claims by KSR and its progeny, and the heightened written description requirement in a post-Centocor v. Abbott environment, the rules for obtaining immunological patents are as complex as ever. ACI’s faculty of industry leaders will discuss the process for obtaining antibody and immune-related patents, share the latest best practices with you, and give you the chance to brainstorm with peers. Do not miss this opportunity to stay on the cutting edge.
Specific topics to be discussed include:
- Drafting immunological claims in an increasingly hostile patenting environment
- Handling written description and enablement issues post-Centocor v. Abbott
- Addressing the evolving obviousness standard and its effect on antibody patenting
- Developing guidelines for drafting antibody patents when filing in Europe
- Tackling claim construction issues with antibody patents
- Considering how antibody claims can be enforced
